Cargando…
Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms
Treatment of leishmaniasis is a challenging subject. Although available, chemotherapy is limited, presenting toxicity and adverse effects. New drugs with antileishmanial activity are being investigated, such as antiparasitic compounds derived from plants. In this work, we investigated the antileishm...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950538/ https://www.ncbi.nlm.nih.gov/pubmed/33718267 http://dx.doi.org/10.3389/fcimb.2021.615814 |
_version_ | 1783663571604865024 |
---|---|
author | Rizk, Yasmin Silva Santos-Pereira, Sandy Gervazoni, Luiza Hardoim, Daiana de Jesus Cardoso, Flávia de Oliveira de Souza, Celeste da Silva Freitas Pelajo-Machado, Marcelo Carollo, Carlos Alexandre de Arruda, Carla Cardozo Pinto Almeida-Amaral, Elmo Eduardo Zaverucha-do-Valle, Tânia Calabrese, Kátia da Silva |
author_facet | Rizk, Yasmin Silva Santos-Pereira, Sandy Gervazoni, Luiza Hardoim, Daiana de Jesus Cardoso, Flávia de Oliveira de Souza, Celeste da Silva Freitas Pelajo-Machado, Marcelo Carollo, Carlos Alexandre de Arruda, Carla Cardozo Pinto Almeida-Amaral, Elmo Eduardo Zaverucha-do-Valle, Tânia Calabrese, Kátia da Silva |
author_sort | Rizk, Yasmin Silva |
collection | PubMed |
description | Treatment of leishmaniasis is a challenging subject. Although available, chemotherapy is limited, presenting toxicity and adverse effects. New drugs with antileishmanial activity are being investigated, such as antiparasitic compounds derived from plants. In this work, we investigated the antileishmanial activity of the biflavonoid amentoflavone on the protozoan Leishmania amazonensis. Although the antileishmanial activity of amentoflavone has already been reported in vitro, the mechanisms involved in the parasite death, as well as its action in vivo, remain unknown. Amentoflavone demonstrated activity on intracellular amastigotes in macrophages obtained from BALB/c mice (IC(50) 2.3 ± 0.93 μM). No cytotoxicity was observed and the selectivity index was estimated as greater than 10. Using BALB/c mice infected with L. amazonensis we verified the effect of an intralesional treatment with amentoflavone (0.05 mg/kg/dose, in a total of 5 doses every 4 days). Parasite quantification demonstrated that amentoflavone reduced the parasite load in treated footpads (46.3% reduction by limiting dilution assay and 56.5% reduction by Real Time Polymerase Chain Reaction). Amentoflavone decreased the nitric oxide production in peritoneal macrophages obtained from treated animals. The treatment also increased the expression of ferritin and decreased iNOS expression at the site of infection. Furthemore, it increased the production of ROS in peritoneal macrophages infected in vitro. The increase of ROS in vitro, associated with the reduction of NO and iNOS expression in vivo, points to the antioxidant/prooxidant potential of amentoflavone, which may play an important role in the balance between inflammatory and anti-inflammatory patterns at the infection site. Taken together these results suggest that amentoflavone has the potential to be used in the treatment of cutaneous leishmaniasis, working as an ally in the control and development of the lesion. |
format | Online Article Text |
id | pubmed-7950538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79505382021-03-12 Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms Rizk, Yasmin Silva Santos-Pereira, Sandy Gervazoni, Luiza Hardoim, Daiana de Jesus Cardoso, Flávia de Oliveira de Souza, Celeste da Silva Freitas Pelajo-Machado, Marcelo Carollo, Carlos Alexandre de Arruda, Carla Cardozo Pinto Almeida-Amaral, Elmo Eduardo Zaverucha-do-Valle, Tânia Calabrese, Kátia da Silva Front Cell Infect Microbiol Cellular and Infection Microbiology Treatment of leishmaniasis is a challenging subject. Although available, chemotherapy is limited, presenting toxicity and adverse effects. New drugs with antileishmanial activity are being investigated, such as antiparasitic compounds derived from plants. In this work, we investigated the antileishmanial activity of the biflavonoid amentoflavone on the protozoan Leishmania amazonensis. Although the antileishmanial activity of amentoflavone has already been reported in vitro, the mechanisms involved in the parasite death, as well as its action in vivo, remain unknown. Amentoflavone demonstrated activity on intracellular amastigotes in macrophages obtained from BALB/c mice (IC(50) 2.3 ± 0.93 μM). No cytotoxicity was observed and the selectivity index was estimated as greater than 10. Using BALB/c mice infected with L. amazonensis we verified the effect of an intralesional treatment with amentoflavone (0.05 mg/kg/dose, in a total of 5 doses every 4 days). Parasite quantification demonstrated that amentoflavone reduced the parasite load in treated footpads (46.3% reduction by limiting dilution assay and 56.5% reduction by Real Time Polymerase Chain Reaction). Amentoflavone decreased the nitric oxide production in peritoneal macrophages obtained from treated animals. The treatment also increased the expression of ferritin and decreased iNOS expression at the site of infection. Furthemore, it increased the production of ROS in peritoneal macrophages infected in vitro. The increase of ROS in vitro, associated with the reduction of NO and iNOS expression in vivo, points to the antioxidant/prooxidant potential of amentoflavone, which may play an important role in the balance between inflammatory and anti-inflammatory patterns at the infection site. Taken together these results suggest that amentoflavone has the potential to be used in the treatment of cutaneous leishmaniasis, working as an ally in the control and development of the lesion. Frontiers Media S.A. 2021-02-25 /pmc/articles/PMC7950538/ /pubmed/33718267 http://dx.doi.org/10.3389/fcimb.2021.615814 Text en Copyright © 2021 Rizk, Santos-Pereira, Gervazoni, Hardoim, Cardoso, de Souza, Pelajo-Machado, Carollo, de Arruda, Almeida-Amaral, Zaverucha-do-Valle and Calabrese http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Rizk, Yasmin Silva Santos-Pereira, Sandy Gervazoni, Luiza Hardoim, Daiana de Jesus Cardoso, Flávia de Oliveira de Souza, Celeste da Silva Freitas Pelajo-Machado, Marcelo Carollo, Carlos Alexandre de Arruda, Carla Cardozo Pinto Almeida-Amaral, Elmo Eduardo Zaverucha-do-Valle, Tânia Calabrese, Kátia da Silva Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms |
title | Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms |
title_full | Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms |
title_fullStr | Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms |
title_full_unstemmed | Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms |
title_short | Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms |
title_sort | amentoflavone as an ally in the treatment of cutaneous leishmaniasis: analysis of its antioxidant/prooxidant mechanisms |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950538/ https://www.ncbi.nlm.nih.gov/pubmed/33718267 http://dx.doi.org/10.3389/fcimb.2021.615814 |
work_keys_str_mv | AT rizkyasminsilva amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT santospereirasandy amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT gervazoniluiza amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT hardoimdaianadejesus amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT cardosoflaviadeoliveira amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT desouzacelestedasilvafreitas amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT pelajomachadomarcelo amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT carollocarlosalexandre amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT dearrudacarlacardozopinto amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT almeidaamaralelmoeduardo amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT zaveruchadovalletania amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms AT calabresekatiadasilva amentoflavoneasanallyinthetreatmentofcutaneousleishmaniasisanalysisofitsantioxidantprooxidantmechanisms |